HIV-1 gene therapy: promise for the future

Retroviruses and opportunistic infections--eighth annual conference.

IDrugs : the investigational drugs journal·2005

Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.

Gene therapy·2004

Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.

Gene therapy·2004

Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.

Infection·2004

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Blood·2001

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.

The Journal of biological chemistry·2001

T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.

Advances in pharmacology (San Diego, Calif.)·2026

Tracking therapeutic T cells in vivo.

Advances in pharmacology (San Diego, Calif.)·2026

In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.

Advances in pharmacology (San Diego, Calif.)·2026

Transient T cell therapies.

Advances in pharmacology (San Diego, Calif.)·2026

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Advances in pharmacology (San Diego, Calif.)·2026

Engineering T cell metabolism to enhance therapeutic efficacy.

Advances in pharmacology (San Diego, Calif.)·2026

New-Onset Raynaud Phenomenon during Ropeginterferon Alfa-2b Therapy for Polycythemia Vera: A Case Report and Review of the Literature.

Case reports in oncology·2026

131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy.

Materials today. Bio·2026

Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series.

Skin appendage disorders·2026

Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.

Blood neoplasia·2026

Machine learning driven precision medicine in tacrolimus dosing: current research and future perspectives in liver and kidney transplantation.

Frontiers in immunology·2026

Modular engineered outer membrane vesicles for synergistic cancer immunotherapy via PD-L1 blockade and epigenetic reprogramming.

Frontiers in immunology·2026

Related Experiment Videos

HIV-1 gene therapy: promise for the future

Related Concept Videos

Retroviruses and opportunistic infections--eighth annual conference.

Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.

Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.

Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.

T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.

Tracking therapeutic T cells in vivo.

In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.

Transient T cell therapies.

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Engineering T cell metabolism to enhance therapeutic efficacy.

New-Onset Raynaud Phenomenon during Ropeginterferon Alfa-2b Therapy for Polycythemia Vera: A Case Report and Review of the Literature.

131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy.

Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series.

Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.

Machine learning driven precision medicine in tacrolimus dosing: current research and future perspectives in liver and kidney transplantation.

Modular engineered outer membrane vesicles for synergistic cancer immunotherapy via PD-L1 blockade and epigenetic reprogramming.

Related Experiment Videos

HIV-1 gene therapy: promise for the future

Related Concept Videos

Related Articles